* Diebold Nixdorf Inc DBD.N DBD is expected to show a
rise in
quarterly revenue when it reports results on May 2 for the
period ending March 31 2024
* The North Canton Ohio-based company is expected to report
a
2.0% increase in revenue to $875.648 million from $858.1 million
a year ago, according to the mean estimate from 2 analysts,
based on LSEG data.
* LSEG's mean analyst estimate for Diebold Nixdorf Inc is
for
earnings of 23 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Diebold
Nixdorf
Inc is $41.50, above its last closing price of $32.60.
This summary was machine generated April 30 at 12:59 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)